Cryosurgery For Prostate Cancer
Published on Mar 13 2010, in the categories: Alternative treatments, News, Possible solutions, Therapies, Useful Info
Cryotherapy is a form of treatment for prostate cancer. The purpose of this technique is to eradicate the prostate cancer through freezing of affected tissue. This therapy consists in inserting needles into the prostate gland under anesthesia.
<-336x280 Large Rectangle - center->
The needles are inserted into the prostate gland through the perineum which is the area between the anus and the scrotum. The needles are ultra-thin. This process destroys the entire prostate and the cancerous cells. The ultrasound helps doctor to accurately guide the needles and to precisely shape the ice balls and the size and shape.
The cryotherapy is an efficient treatment for all patients who have failed other previous radiation treatment. This is used to cure prostate cancer in the stage T2c or above when patients don't want to go through the risk of a major surgery. The cryotherpy has its downside in the decreased sexual function.
The good thing is that patients can recover well after this treatment. This can be used as a secondary treatment for cases when other treatment has failed. The major risk from cryotherapy is the erectile dysfunction. The freezing of the prostate during the procedure can affect the nerve associated with the erection. The benefit from the cryotherapy is that this treatment has a very small recovery time.
Patients can return to their normal life in a few days. This procedure can be done in less than two hours. Besides impotence might be other side effects related to the procedure such as scrotal swelling, blood in the urine, moderate pelvic pain and mild urinary urgency. These side effects can go away in a few weeks after the treatment. This treatment of prostate cancer has his advantages and that's why a clean method of treatment is. With the use of ultrasound technology and these ultra-thin needles this technique allows a very accurate treatment of only the affected tissue.
The prostate cancer continues to grow and affect nearby tissues and without any treatment can develop into a metastasized form. In the metastasized form there is very difficult to use an efficient treatment. After the surgery the doctor may recommend some medicines such as: antibiotics to help prevent eventual infections; anti nausea medicine to calm the stomach after taking pain medicine that can produce vomiting.
Many times anti nausea and anti pain medicine are given in the same time. Other medicines that are prescribed after the surgery are hormone medicines that aim to block testosterone which can influence the development of tumor.
The hormone medicines after the surgery help reduce the tumor and also prevent any further problems. Other medicines are pain medicines to decrease the pain after the procedure. The diet can influence the recovery after the cryotherapy surgery. Patients treated using this type of therapy may drink lots of liquids such as water, juice or soda pop. When there are no problems after this, the patient can eat soft foods such as applesauce, ice cream, custard. Once there are no problems in eating all of this, the patient can eat normal food.
<-336x280 Large Rectangle - center->
The needles are inserted into the prostate gland through the perineum which is the area between the anus and the scrotum. The needles are ultra-thin. This process destroys the entire prostate and the cancerous cells. The ultrasound helps doctor to accurately guide the needles and to precisely shape the ice balls and the size and shape.
The cryotherapy is an efficient treatment for all patients who have failed other previous radiation treatment. This is used to cure prostate cancer in the stage T2c or above when patients don't want to go through the risk of a major surgery. The cryotherpy has its downside in the decreased sexual function.
The good thing is that patients can recover well after this treatment. This can be used as a secondary treatment for cases when other treatment has failed. The major risk from cryotherapy is the erectile dysfunction. The freezing of the prostate during the procedure can affect the nerve associated with the erection. The benefit from the cryotherapy is that this treatment has a very small recovery time.
Patients can return to their normal life in a few days. This procedure can be done in less than two hours. Besides impotence might be other side effects related to the procedure such as scrotal swelling, blood in the urine, moderate pelvic pain and mild urinary urgency. These side effects can go away in a few weeks after the treatment. This treatment of prostate cancer has his advantages and that's why a clean method of treatment is. With the use of ultrasound technology and these ultra-thin needles this technique allows a very accurate treatment of only the affected tissue.
The prostate cancer continues to grow and affect nearby tissues and without any treatment can develop into a metastasized form. In the metastasized form there is very difficult to use an efficient treatment. After the surgery the doctor may recommend some medicines such as: antibiotics to help prevent eventual infections; anti nausea medicine to calm the stomach after taking pain medicine that can produce vomiting.
Many times anti nausea and anti pain medicine are given in the same time. Other medicines that are prescribed after the surgery are hormone medicines that aim to block testosterone which can influence the development of tumor.
The hormone medicines after the surgery help reduce the tumor and also prevent any further problems. Other medicines are pain medicines to decrease the pain after the procedure. The diet can influence the recovery after the cryotherapy surgery. Patients treated using this type of therapy may drink lots of liquids such as water, juice or soda pop. When there are no problems after this, the patient can eat soft foods such as applesauce, ice cream, custard. Once there are no problems in eating all of this, the patient can eat normal food.
Prostate Cancer News
Published on Mar 03 2010, in the categories: News, Related topics, Useful Info
You can find prostate cancer news all over the internet. I have been searching for the latest prostate cancer news and this is what I found out. "Thanks to the blood test PSA (prostate specific antigen), for 23 years we can diagnose early stage prostate cancer," explained Martin Sanda, professor at the Faculty of medicine of Harvard University, lead author of the study.
<-336x280 Large Rectangle - center->
PSA (prostate specific antigen) is a protein produced by prostate and its level increases when the prostate is increased or when there is cancer. "This test allows the detection of small tumors in the prostate, which are not dangerous in the short or long term," added Martin Sanda. The test allows doctors to offer much earlier treatment and with a higher success rate instead of those various aggressive treatment of prostate cancer cases.
The authors analyzed the findings of an extensive study provided data on 51,529 men who participated, who were monitored since 1986. Of these, 3331 were diagnosed with cancer during 1986 to 2007. Furthermore, the study revealed that 342 of the volunteers diagnosed with cancer, representing about 10%, have decided to delay starting treatment with at least one year.
At 10 years of diagnosis, half of the volunteers who have decided to wait, have not yet started any treatment. The study authors analyzed medical data for all patients, eight years after diagnosis, and comparisons were made between those who opted for aggressive treatment (surgery, radiotherapy or hormonal therapy) and those who have decided to delay their treatment.
"We found that the mortality rate was very low among men suffering from prostate cancer of small risk," said Martin Sanda. Analysis showed that only 2% of men suffering from this form of cancer of the prostate and the delayed start of treatment had died, compared with 1% of patients suffering from a similar form of cancer that started treatment early, the researchers explained American, which indicated that such differences are unimportant in terms of statistics.
According to this study, most men diagnosed with low risk prostate cancer who deferred to start with, on average, eight years - or even 20 years - still feel good. They thus avoided and frequent inconvenience caused by cancer treatments. According to experts, there are three types of cancer prostate cancer with large tumors, which grow at a rapid pace, medium-sized cancer tumors, small tumor cancer that develops slowly.
According to another study, published in the Journal of the National Cancer Institute, PSA test led to a "supra diagnosis" of prostate cancer in the past 23 years. After the launch of this test on the market, in 1986, about 1.3 million men were diagnosed with prostate cancer; these are cases which were not previously detected. Of these, one million were treated for cancer and suffered "unnecessarily inconvenience this treatment - the financial consequences and the anguish caused by this experience," explained the authors. After 1986, the number of men diagnosed with prostate cancer has tripled among patients aged 50 and 59 years and increased over seven times in patients who have not yet reached 50 years.
<-336x280 Large Rectangle - center->
PSA (prostate specific antigen) is a protein produced by prostate and its level increases when the prostate is increased or when there is cancer. "This test allows the detection of small tumors in the prostate, which are not dangerous in the short or long term," added Martin Sanda. The test allows doctors to offer much earlier treatment and with a higher success rate instead of those various aggressive treatment of prostate cancer cases.
The authors analyzed the findings of an extensive study provided data on 51,529 men who participated, who were monitored since 1986. Of these, 3331 were diagnosed with cancer during 1986 to 2007. Furthermore, the study revealed that 342 of the volunteers diagnosed with cancer, representing about 10%, have decided to delay starting treatment with at least one year.
At 10 years of diagnosis, half of the volunteers who have decided to wait, have not yet started any treatment. The study authors analyzed medical data for all patients, eight years after diagnosis, and comparisons were made between those who opted for aggressive treatment (surgery, radiotherapy or hormonal therapy) and those who have decided to delay their treatment.
"We found that the mortality rate was very low among men suffering from prostate cancer of small risk," said Martin Sanda. Analysis showed that only 2% of men suffering from this form of cancer of the prostate and the delayed start of treatment had died, compared with 1% of patients suffering from a similar form of cancer that started treatment early, the researchers explained American, which indicated that such differences are unimportant in terms of statistics.
According to this study, most men diagnosed with low risk prostate cancer who deferred to start with, on average, eight years - or even 20 years - still feel good. They thus avoided and frequent inconvenience caused by cancer treatments. According to experts, there are three types of cancer prostate cancer with large tumors, which grow at a rapid pace, medium-sized cancer tumors, small tumor cancer that develops slowly.
According to another study, published in the Journal of the National Cancer Institute, PSA test led to a "supra diagnosis" of prostate cancer in the past 23 years. After the launch of this test on the market, in 1986, about 1.3 million men were diagnosed with prostate cancer; these are cases which were not previously detected. Of these, one million were treated for cancer and suffered "unnecessarily inconvenience this treatment - the financial consequences and the anguish caused by this experience," explained the authors. After 1986, the number of men diagnosed with prostate cancer has tripled among patients aged 50 and 59 years and increased over seven times in patients who have not yet reached 50 years.